Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeUnder the Influence: The Interplay among Industry, Publishing, and Drug Regulation.Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option?The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis.From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant FindingsCanadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsFive potential therapeutic agents as antidepressants: a brief review and future directions.The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence.Efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients aged 55 years or older.Factors contributing to the increasing placebo response in antidepressant trials.Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder.Why are new antidepressants failing to make the grade for approval?
P2860
Q26796436-BBC5B7CC-3A71-4614-BD68-3D15887FC884Q26797416-2501822E-48DF-4327-A518-BE13D65DCEC0Q34046215-1198EB16-FFA9-41A1-8720-9B1FAC122EECQ35426685-1980D352-A6B1-4ED7-B724-01B17B898786Q36008269-ED358CED-D35D-47B7-9545-7465071CF40CQ36601436-663B39C1-6B16-4A59-BFAA-387D1FB7060FQ37197216-8309F6CC-CD66-4DC0-B1D8-292D1341F525Q38574831-16D6096C-21A4-4FB4-8F02-1674E49F2F91Q38862355-23EDDE21-E389-423D-ACAD-00B0E2ABAEEBQ39169446-B60507D5-B891-4B5B-BFB0-5C6D01D5F8F2Q41411906-17D2EFDB-1409-4285-9691-0D65CD9BC49CQ47657288-D3019E71-04B9-4913-9E5C-5B4F8D59AA90Q53398572-71681A10-CC49-4492-9A45-56FDFEA60726
P2860
Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@ast
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@en
type
label
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@ast
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@en
prefLabel
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@ast
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@en
P2093
P2860
P356
P1476
Vortioxetine: a meta-analysis ...... t of major depressive disorder
@en
P2093
Ashwin A Patkar
Changsu Han
Chi-Un Pae
Praksh S Masand
Sheng-Min Wang
Soo-Jung Lee
P2860
P304
P356
10.1503/JPN.140120
P577
2015-05-01T00:00:00Z